Literature DB >> 21697053

Maculopapular-type drug eruption caused by entecavir.

Shigenori Yamada, Yu Sawada, Motonobu Nakamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21697053     DOI： 10.1684/ejd.2011.1411

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  3 in total

1.  Delayed hypersensitivity reaction resulting in maculopapular-type eruption due to entecavir in the treatment of chronic hepatitis B.

Authors:  Jeong Tae Kim; Hye Won Jeong; Ki Hwa Choi; Tae Young Yoon; Nohyun Sung; Young Ki Choi; Eun Ha Kim; Hee Bok Chae
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

Review 2.  A case of entecavir-associated bullous fixed drug eruption and a review of literature.

Authors:  Selami Aykut Temiz; İlkay Özer; Arzu Ataseven; Sıddıka Fındık
Journal:  Turk J Gastroenterol       Date:  2019-03       Impact factor: 1.852

3.  "Black box warning" rash with entecavir - case report.

Authors:  Xiong Khee Cheong; Zhiqin Wong; Norazirah Md Nor; Bang Rom Lee
Journal:  BMC Gastroenterol       Date:  2020-09-18       Impact factor: 3.067
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.